ORC Quote, Financials, Valuation and Earnings

UC Asset LP has a net margin of 50.96% compared to Orchid Island Capital, Inc.'s net margin of --. Orchid Island Capital, Inc.'s return on equity of 16.25% beat UC Asset LP's return on equity of --.

Orchid Island Capital, Inc. has a consensus price target of $7.50, signalling downside risk potential of -1.45%. On the other hand UC Asset LP has an analysts' consensus of -- which suggests that it could grow by 834.6%. Given that UC Asset LP has higher upside potential than Orchid Island Capital, Inc., analysts believe UC Asset LP is more attractive than Orchid Island Capital, Inc..

Orchid Island Capital, Inc. has a beta of 1.681, which suggesting that the stock is 68.1% more volatile than S&P 500. In comparison UC Asset LP has a beta of 3.020, suggesting its more volatile than the S&P 500 by 201.974%.

Orchid Island Capital, Inc. has a quarterly dividend of $0.12 per share corresponding to a yield of 18.92%. UC Asset LP offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orchid Island Capital, Inc. pays 116.18% of its earnings as a dividend. UC Asset LP pays out -- of its earnings as a dividend.

Orchid Island Capital, Inc. quarterly revenues are $202.9M, which are larger than UC Asset LP quarterly revenues of --. Orchid Island Capital, Inc.'s net income of $103.4M is higher than UC Asset LP's net income of --. Notably, Orchid Island Capital, Inc.'s price-to-earnings ratio is 7.33x while UC Asset LP's PE ratio is 329.22x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orchid Island Capital, Inc. is 2.05x versus 3.47x for UC Asset LP. Usually stocks with elevated PS ratios are considered overvalued.

VG Life Sciences has a net margin of 50.96% compared to Orchid Island Capital, Inc.'s net margin of --. Orchid Island Capital, Inc.'s return on equity of 16.25% beat VG Life Sciences's return on equity of --.

Orchid Island Capital, Inc. has a consensus price target of $7.50, signalling downside risk potential of -1.45%. On the other hand VG Life Sciences has an analysts' consensus of -- which suggests that it could fall by --. Given that Orchid Island Capital, Inc. has higher upside potential than VG Life Sciences, analysts believe Orchid Island Capital, Inc. is more attractive than VG Life Sciences.

Orchid Island Capital, Inc. has a beta of 1.681, which suggesting that the stock is 68.1% more volatile than S&P 500. In comparison VG Life Sciences has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Orchid Island Capital, Inc. has a quarterly dividend of $0.12 per share corresponding to a yield of 18.92%. VG Life Sciences offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Orchid Island Capital, Inc. pays 116.18% of its earnings as a dividend. VG Life Sciences pays out -- of its earnings as a dividend.

Orchid Island Capital, Inc. quarterly revenues are $202.9M, which are larger than VG Life Sciences quarterly revenues of --. Orchid Island Capital, Inc.'s net income of $103.4M is higher than VG Life Sciences's net income of --. Notably, Orchid Island Capital, Inc.'s price-to-earnings ratio is 7.33x while VG Life Sciences's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orchid Island Capital, Inc. is 2.05x versus -- for VG Life Sciences. Usually stocks with elevated PS ratios are considered overvalued.

Weyerhaeuser Co. has a net margin of 50.96% compared to Orchid Island Capital, Inc.'s net margin of 4.8%. Orchid Island Capital, Inc.'s return on equity of 16.25% beat Weyerhaeuser Co.'s return on equity of 3.43%.

Orchid Island Capital, Inc. has a consensus price target of $7.50, signalling downside risk potential of -1.45%. On the other hand Weyerhaeuser Co. has an analysts' consensus of $30.91 which suggests that it could grow by 16.03%. Given that Weyerhaeuser Co. has higher upside potential than Orchid Island Capital, Inc., analysts believe Weyerhaeuser Co. is more attractive than Orchid Island Capital, Inc..

Orchid Island Capital, Inc. has a beta of 1.681, which suggesting that the stock is 68.1% more volatile than S&P 500. In comparison Weyerhaeuser Co. has a beta of 1.033, suggesting its more volatile than the S&P 500 by 3.253%.

Orchid Island Capital, Inc. has a quarterly dividend of $0.12 per share corresponding to a yield of 18.92%. Weyerhaeuser Co. offers a yield of 3.15% to investors and pays a quarterly dividend of $0.21 per share. Orchid Island Capital, Inc. pays 116.18% of its earnings as a dividend. Weyerhaeuser Co. pays out 187.58% of its earnings as a dividend. Neither of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Orchid Island Capital, Inc. quarterly revenues are $202.9M, which are smaller than Weyerhaeuser Co. quarterly revenues of $1.5B. Orchid Island Capital, Inc.'s net income of $103.4M is higher than Weyerhaeuser Co.'s net income of $74M. Notably, Orchid Island Capital, Inc.'s price-to-earnings ratio is 7.33x while Weyerhaeuser Co.'s PE ratio is 59.50x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Orchid Island Capital, Inc. is 2.05x versus 2.79x for Weyerhaeuser Co.. Usually stocks with elevated PS ratios are considered overvalued.